StockDriftsStockDriftsTop 50 Baker Bros Advisors LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte Corporation | 16.62% | 30.74M | $2.89B | +0.00%(+421) | $12.16(+861.24%) | 2026-03-31 | |
| ONC | BeOne Medicines Ltd. | 15% | 8.80M | $2.61B | +0.00%(+0) | $71.24(+317.81%) | 2026-03-31 | |
| INSM | Insmed Incorporated | 6.97% | 7.42M | $1.21B | +12.56%(+828.37K) | $61.02(+82.88%) | 2026-03-31 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 6.44% | 2.14M | $1.12B | +0.00%(+0) | $180.21(+193.05%) | 2026-03-31 | |
| ACAD | ACADIA Pharmaceuticals Inc. | 5.48% | 42.90M | $954.9M | +0.00%(+0) | $16.39(+58.41%) | 2026-03-31 | |
| RVMD | Revolution Medicines, Inc. | 5.34% | 9.56M | $929.3M | +1.06%(+100.00K) | $30.42(+522.15%) | 2026-03-31 | |
| CELC | Celcuity Inc. | 5.19% | 7.92M | $903.5M | +0.00%(+0) | $28.85(+274.12%) | 2026-03-31 | |
| KOD | Kodiak Sciences Inc. | 4.36% | 19.92M | $759.3M | +0.00%(+0) | $29.31(+31.47%) | 2026-03-31 | |
| KYMR | Kymera Therapeutics, Inc. | 4.14% | 8.66M | $721.1M | +0.00%(+0) | $41.46(+173.79%) | 2026-03-31 | |
| SMMT | Summit Therapeutics Inc. | 3.96% | 36.39M | $690.0M | +0.00%(+0) | $10.75(+43.45%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +15.95% | +55.90% |
| Top 20 Holdings Unweighted | +19.30% | +69.81% |
Sign up free to track Baker Bros Advisors LP, compare funds side by side, and get alerts the moment positions change.